ORASURE TECHNOLOGIES, INC Accumulated Other Comprehensive Income
ORASURE TECHNOLOGIES, INC (OSUR) had Accumulated Other Comprehensive Income of -$21.90 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-07
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$21.90M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$20.04M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$18.40M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$20.17M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$21.90M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | -$20.04M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | -$18.40M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | -$20.17M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | -$17.37M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | -$24.12M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | -$24.36M 10-K · filed 2026-03-09 | |
| 2024-09-30 | -$17.20M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | -$18.63M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | -$17.50M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$14.94M 10-K · filed 2025-03-07 | |
| 2023-09-30 | -$17.37M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | -$14.56M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | -$17.42M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | -$18.43M 10-K · filed 2024-03-11 | |
| 2022-09-30 | -$22.33M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | -$12.51M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | -$8.25M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | -$10.08M 10-K · filed 2023-03-03 | |
| 2021-09-30 | -$10.72M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | -$6.44M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | -$7.72M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | -$9.10M 10-K · filed 2022-03-01 | |
| 2020-09-30 | -$15.60M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | -$17.28M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | -$21.80M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | -$12.14M 10-K · filed 2021-03-01 | |
| 2019-09-30 | -$14.68M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | -$13.31M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | -$15.98M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$18.71M 10-K · filed 2020-03-02 | |
| 2018-09-30 | -$12.71M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$14.46M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$13.01M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | -$10.34M 10-K · filed 2019-02-28 | |
| 2017-09-30 | -$9.64M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$11.96M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | -$13.77M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | -$14.22M 10-K · filed 2018-02-28 | |
| 2016-09-30 | -$13.14M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | -$12.41M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | -$12.77M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | -$15.64M 10-K · filed 2017-03-14 | |
| 2015-09-30 | -$13.88M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | -$11.03M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | -$11.66M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | -$7.85M 10-K · filed 2016-03-14 | |
| 2014-09-30 | -$6.25M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | -$3.95M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | -$5.58M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | -$3.80M 10-K · filed 2015-03-12 | |
| 2013-09-30 | -$2.38M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | -$3.25M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | -$1.79M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | -$666.00K 10-K · filed 2014-03-14 | |
| 2012-09-30 | -$232.20K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | -$1.72M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | -$858.66K 10-Q · filed 2012-05-09 | |
| 2011-12-31 | -$1.96M 10-K · filed 2013-03-13 | -$1.96M 10-K · filed 2012-03-14 |
| 2011-09-30 | -$3.07M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | -$233.83K 10-Q · filed 2011-08-05 | |
| 2010-12-31 | -$235.26K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |